ATE365800T1 - Therapeutische verwendungen von il-17 homologe polypeptide - Google Patents
Therapeutische verwendungen von il-17 homologe polypeptideInfo
- Publication number
- ATE365800T1 ATE365800T1 AT99923088T AT99923088T ATE365800T1 AT E365800 T1 ATE365800 T1 AT E365800T1 AT 99923088 T AT99923088 T AT 99923088T AT 99923088 T AT99923088 T AT 99923088T AT E365800 T1 ATE365800 T1 AT E365800T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- present
- nucleic acid
- therapeutic uses
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8557998P | 1998-05-15 | 1998-05-15 | |
US11362198P | 1998-12-23 | 1998-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE365800T1 true ATE365800T1 (de) | 2007-07-15 |
Family
ID=26772882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99923088T ATE365800T1 (de) | 1998-05-15 | 1999-05-14 | Therapeutische verwendungen von il-17 homologe polypeptide |
Country Status (14)
Country | Link |
---|---|
US (6) | US7217412B2 (de) |
EP (2) | EP2333069A3 (de) |
JP (1) | JP3577586B2 (de) |
AT (1) | ATE365800T1 (de) |
AU (1) | AU740405B2 (de) |
CA (1) | CA2328496C (de) |
CY (1) | CY1106885T1 (de) |
DE (1) | DE69936382T3 (de) |
DK (1) | DK1076703T4 (de) |
ES (1) | ES2292242T5 (de) |
IL (3) | IL138930A0 (de) |
NZ (1) | NZ508878A (de) |
PT (1) | PT1076703E (de) |
WO (1) | WO1999060127A2 (de) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
US8212004B2 (en) | 1999-03-02 | 2012-07-03 | Human Genome Sciences, Inc. | Neutrokine-alpha fusion proteins |
US6579520B2 (en) * | 1998-05-15 | 2003-06-17 | Genentech, Inc. | IL-17 related mammalian cytokine polypeptides (IL-17E) |
US6562578B1 (en) | 1999-01-11 | 2003-05-13 | Schering Corporation | IL-17-like cytokine binding compounds and antibodies |
US20050147609A1 (en) * | 1998-05-15 | 2005-07-07 | Genentech, Inc. | Use of anti-IL-17 antibody for the treatment of cartilage damaged by osteoarthritis |
EP3112468A1 (de) * | 1998-05-15 | 2017-01-04 | Genentech, Inc. | Il-17-homologe polypeptide und therapeutische verwendung davon |
US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
DE69936382T3 (de) | 1998-05-15 | 2011-07-07 | Genentech, Inc., Calif. | Therapeutische verwendungen von il-17 homologe polypeptide |
US20010023070A1 (en) * | 1998-05-29 | 2001-09-20 | Reinhard Ebner | Interleukins-21 and 22 |
EP1082433A4 (de) * | 1998-05-29 | 2003-01-02 | Human Genome Sciences Inc | Interleukine 21 und 22 |
WO2000020593A1 (en) * | 1998-10-02 | 2000-04-13 | Eli Lilly And Company | Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and uses thereof |
PT1141297E (pt) * | 1999-01-11 | 2010-01-06 | Schering Corp | Citoquinas de mamíferos relacionadas com a interleucina-17. polinucleótidos que as codificam. utilizações |
WO2000042187A1 (en) * | 1999-01-11 | 2000-07-20 | Schering Corporation | Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses |
WO2000061754A2 (en) * | 1999-04-09 | 2000-10-19 | Curagen Corporation | Human proteins and polynucleotides encoding them |
US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
JP2016047051A (ja) * | 1999-12-23 | 2016-04-07 | ジェネンテック, インコーポレイテッド | Il−17相同的ポリペプチドとその治療上の用途 |
ATE444361T1 (de) * | 1999-12-23 | 2009-10-15 | Genentech Inc | Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen |
DK1897944T3 (da) * | 1999-12-23 | 2011-10-24 | Genentech Inc | IL-17 homologe polypeptider og terapeutisk anvendelse deraf |
WO2001059120A2 (en) * | 2000-02-08 | 2001-08-16 | Amgen, Inc. | Il-17 like molecules and uses thereof |
US20030203451A1 (en) * | 2000-08-24 | 2003-10-30 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
DE60136921D1 (de) | 2000-04-18 | 2009-01-22 | Schering Corp | Medizinische Verwendung von IL-174 Agonisten und Antagonisten |
US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7879328B2 (en) | 2000-06-16 | 2011-02-01 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to B lymphocyte stimulator |
AU6842701A (en) | 2000-06-16 | 2002-01-14 | Human Genome Sciences Inc | Antibodies that immunospecifically bind to blys |
DE60125563T2 (de) * | 2000-10-13 | 2007-10-04 | Eli Lilly And Co., Indianapolis | Verfahren zur verwendung eines humanen il-17 verwandten polypeptids zur behandlung von krankheiten |
WO2002058717A2 (en) | 2000-10-18 | 2002-08-01 | Immunex Corporation | Methods for treating rheumatoid arthritis using il-17 antagonists |
AU2002225714A1 (en) * | 2000-11-10 | 2002-05-21 | The Regents Of The University Of California | Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage |
WO2002064739A2 (en) * | 2001-02-09 | 2002-08-22 | Johns Hopkins University | A cytokine related structurally to il-17 |
EP1379278A4 (de) * | 2001-03-26 | 2004-08-11 | Zymogenetics Inc | Verfahren zur auslösung der proliferation von retinalen stammzellen |
JP2007535930A (ja) * | 2004-05-03 | 2007-12-13 | シェーリング コーポレイション | 皮膚の炎症を予測するためのil−17発現の使用;処置方法 |
US20050287593A1 (en) | 2004-05-03 | 2005-12-29 | Schering Corporation | Use of cytokine expression to predict skin inflammation; methods of treatment |
CA2569867A1 (en) * | 2004-06-10 | 2005-12-29 | Zymogenetics, Inc. | Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
DE602005005392T2 (de) * | 2004-06-30 | 2009-04-23 | Tyco Electronics Nederland B.V. | Verbinder für elektronische Bauteile |
GB0417487D0 (en) | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
JP2008532936A (ja) * | 2005-02-14 | 2008-08-21 | ワイス | インターロイキン−17f抗体及び他のil−17fシグナル伝達拮抗物質並びにそれらの使用 |
PL1931697T3 (pl) * | 2005-09-28 | 2011-03-31 | Zymogenetics Inc | Antagoniści interleukiny IL-17A i IL-17F oraz sposoby ich zastosowania |
US7467467B2 (en) | 2005-09-30 | 2008-12-23 | Pratt & Whitney Canada Corp. | Method for manufacturing a foam core heat exchanger |
US9168286B2 (en) | 2005-10-13 | 2015-10-27 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive disease |
WO2007123765A2 (en) | 2006-03-31 | 2007-11-01 | Human Genome Sciences Inc. | Neutrokine-alpha and neutrokine-alpha splice variant |
US7833527B2 (en) | 2006-10-02 | 2010-11-16 | Amgen Inc. | Methods of treating psoriasis using IL-17 Receptor A antibodies |
JP2010522564A (ja) | 2007-03-26 | 2010-07-08 | ザイモジェネティクス, インコーポレイテッド | 可溶性il−17ra/rc融合タンパク質および関連する方法 |
WO2008131315A2 (en) * | 2007-04-20 | 2008-10-30 | Amgen Inc. | Jacquelinidentification and method for using the pre-ligand assembly domain of the il-17 receptor |
KR20170023209A (ko) | 2008-05-05 | 2017-03-02 | 노비뮨 에스 에이 | 항-il-17a/il-17f 교차-반응성 항체 및 그의 사용 방법 |
US20100233270A1 (en) | 2009-01-08 | 2010-09-16 | Northwestern University | Delivery of Oligonucleotide-Functionalized Nanoparticles |
CN104974250A (zh) | 2009-05-05 | 2015-10-14 | 诺维莫尼公司 | 抗il-17f抗体及其使用方法 |
EA201891433A3 (ru) | 2010-01-15 | 2019-02-28 | Кирин-Эмджен, Инк. | Состав антитела и терапевтические режимы |
WO2013011368A2 (en) | 2011-07-19 | 2013-01-24 | Teva Pharmaceutical Industries Ltd. | Novel il-17r-ecd mutants |
ES2669984T3 (es) | 2011-10-19 | 2018-05-29 | Morphosys Ag | Antagonistas de IL17C para el tratamiento de trastornos inflamatorios |
US20140274068A1 (en) * | 2013-03-15 | 2014-09-18 | Herbert DAWID | Mobile terminal and method for determining a receive window |
CN106535922A (zh) * | 2014-02-11 | 2017-03-22 | 北京艾棣维欣生物技术有限公司 | 免疫治疗组合物、治疗方法和诊断方法 |
KR20170089013A (ko) * | 2014-12-15 | 2017-08-02 | 모르포시스 아게 | Il-17c에 대한 항체 |
EP3359161A1 (de) | 2015-10-05 | 2018-08-15 | MorphoSys AG | Antagonisten von il-17c zur behandlung und/oder prävention von atopischer dermatitis |
CN108699143B (zh) | 2016-02-19 | 2021-11-09 | 莫佛塞斯公司 | Il-17c的抗体 |
JP7186094B2 (ja) | 2016-05-06 | 2022-12-08 | イグジキュア オペレーティング カンパニー | インターロイキン17受容体mRNAの特異的ノックダウンのためのアンチセンスオリゴヌクレオチド(ASO)を提示するリポソーム系球状核酸(SNA)構築物 |
US11696954B2 (en) | 2017-04-28 | 2023-07-11 | Exicure Operating Company | Synthesis of spherical nucleic acids using lipophilic moieties |
TW201919698A (zh) | 2017-09-25 | 2019-06-01 | 德商莫菲西斯公司 | 異位性皮炎之治療 |
GB201803563D0 (en) | 2018-03-06 | 2018-04-18 | Galapagos Nv | Antibodies and pharmaceutical compositions thereof for the treatment of autoimmune skin diseases |
US10869888B2 (en) | 2018-04-17 | 2020-12-22 | Innovative Cellular Therapeutics CO., LTD. | Modified cell expansion and uses thereof |
US20220348682A1 (en) | 2018-08-30 | 2022-11-03 | Innovative Cellular Therapeutics Holdings, Ltd. | Chimeric antigen receptor cells for treating solid tumor |
CN111197032A (zh) * | 2018-11-16 | 2020-05-26 | 上海斯丹赛生物技术有限公司 | 嵌合抗原受体细胞分泌治疗剂 |
CA3120153A1 (en) * | 2018-11-20 | 2020-05-28 | Innovative Cellular Therapeutics Holdings, Ltd. | Modified cell expressing therapeutic agent and uses thereof |
US10918667B2 (en) | 2018-11-20 | 2021-02-16 | Innovative Cellular Therapeutics CO., LTD. | Modified cell expressing therapeutic agent and uses thereof |
KR20230047693A (ko) * | 2021-10-01 | 2023-04-10 | (주)케어젠 | 탈모 방지 또는 발모 촉진 활성을 갖는 펩타이드와 이의 용도 |
CN114410477B (zh) * | 2021-11-29 | 2023-10-10 | 深圳大学 | 一种诱导型no合成酶的抑制剂及其生产菌株和制备方法 |
Family Cites Families (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4657760A (en) | 1979-03-20 | 1987-04-14 | Ortho Pharmaceutical Corporation | Methods and compositions using monoclonal antibody to human T cells |
JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
WO1981001145A1 (en) | 1979-10-18 | 1981-04-30 | Univ Illinois | Hydrolytic enzyme-activatible pro-drugs |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
ZA811368B (en) | 1980-03-24 | 1982-04-28 | Genentech Inc | Bacterial polypedtide expression employing tryptophan promoter-operator |
US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
US4943529A (en) | 1982-05-19 | 1990-07-24 | Gist-Brocades Nv | Kluyveromyces as a host strain |
US4870009A (en) | 1982-11-22 | 1989-09-26 | The Salk Institute For Biological Studies | Method of obtaining gene product through the generation of transgenic animals |
AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
AU3145184A (en) | 1983-08-16 | 1985-02-21 | Zymogenetics Inc. | High expression of foreign genes in schizosaccharomyces pombe |
US4496689A (en) | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
US4736866A (en) | 1984-06-22 | 1988-04-12 | President And Fellows Of Harvard College | Transgenic non-human mammals |
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
DE3675588D1 (de) | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist. |
US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
JPS63502716A (ja) | 1986-03-07 | 1988-10-13 | マサチューセッツ・インステチュート・オブ・テクノロジー | 糖タンパク安定性の強化方法 |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
US4791192A (en) | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
US4946783A (en) | 1987-01-30 | 1990-08-07 | President And Fellows Of Harvard College | Periplasmic protease mutants of Escherichia coli |
GB8705477D0 (en) | 1987-03-09 | 1987-04-15 | Carlton Med Prod | Drug delivery systems |
US5010182A (en) | 1987-07-28 | 1991-04-23 | Chiron Corporation | DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
US4975278A (en) | 1988-02-26 | 1990-12-04 | Bristol-Myers Company | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
GB8724885D0 (en) | 1987-10-23 | 1987-11-25 | Binns M M | Fowlpox virus promotors |
WO1989005859A1 (en) | 1987-12-21 | 1989-06-29 | The Upjohn Company | Agrobacterium mediated transformation of germinating plant seeds |
AU4005289A (en) | 1988-08-25 | 1990-03-01 | Smithkline Beecham Corporation | Recombinant saccharomyces |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
US5009772A (en) | 1989-02-27 | 1991-04-23 | Kerr-Mcgee Corporation | Solvent extraction process |
WO1990010448A2 (en) | 1989-03-07 | 1990-09-20 | Genentech, Inc. | Covalent conjugates of lipid and oligonucleotide |
DE68927344T2 (de) | 1989-04-28 | 1997-02-20 | Rhein Biotech Proz & Prod Gmbh | Hefezellen der Gattung-Schwanniomyces |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
EP0471796A4 (en) | 1989-05-10 | 1993-05-05 | Sloan Kettering Institute For Cancer Research | Stably transformed eucaryotic cells comprising a foreign transcribable dna under the control of a pol iii promoter |
EP0402226A1 (de) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformationsvektoren für Hefe Yarrowia |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
AU641673B2 (en) | 1989-06-29 | 1993-09-30 | Medarex, Inc. | Bispecific reagents for aids therapy |
FR2649120B1 (fr) | 1989-06-30 | 1994-01-28 | Cayla | Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede |
WO1991004753A1 (en) | 1989-10-02 | 1991-04-18 | Cetus Corporation | Conjugates of antisense oligonucleotides and therapeutic uses thereof |
US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
DE69027443T2 (de) | 1989-10-24 | 1998-03-19 | Gilead Sciences, Inc., Foster City, Calif. | Oligonukleotidanaloga mit neuartigen bindungen |
US5190750A (en) * | 1990-03-09 | 1993-03-02 | Asahi Kasei Kogyo Kabushiki Kaisha | Methods for the treatment of demyelinating disease, uveitis, or graft-versus-host disease using tnf |
JPH03276071A (ja) | 1990-03-27 | 1991-12-06 | Yoshiomi Kondo | 流体及び電磁流体の物理量予測方法 |
US5385915A (en) | 1990-05-16 | 1995-01-31 | The Rockefeller University | Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
WO1992003918A1 (en) | 1990-08-29 | 1992-03-19 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5206161A (en) | 1991-02-01 | 1993-04-27 | Genentech, Inc. | Human plasma carboxypeptidase B |
JPH06507398A (ja) | 1991-05-14 | 1994-08-25 | リプリジェン コーポレーション | Hiv感染治療のための異種複合抗体 |
WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
DK1136556T3 (da) | 1991-11-25 | 2005-10-03 | Enzon Inc | Fremgangsmåde til fremstilling af multivalente antigen-bindende proteiner |
GB9214857D0 (en) | 1992-07-13 | 1992-08-26 | Medical Res Council | Human nucleic acid fragments and their use |
DK0672141T3 (da) | 1992-10-23 | 2003-06-10 | Immunex Corp | Fremgangsmåder til fremstilling af opløselige, oligomere proteiner |
EP0752248B1 (de) | 1992-11-13 | 2000-09-27 | Idec Pharmaceuticals Corporation | Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma |
ES2151541T3 (es) | 1992-12-02 | 2001-01-01 | Alkermes Inc | Microesferas que contienen hormona del crecimiento de liberacion prolongada. |
US5536637A (en) | 1993-04-07 | 1996-07-16 | Genetics Institute, Inc. | Method of screening for cDNA encoding novel secreted mammalian proteins in yeast |
US6562333B1 (en) | 1993-06-14 | 2003-05-13 | Schering Corporation | Purified mammalian CTLA-8 antigens and related reagents |
WO2000073452A2 (en) | 1999-06-02 | 2000-12-07 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
EP0779806B2 (de) | 1994-09-09 | 2008-04-16 | Takeda Pharmaceutical Company Limited | Zubereitung mit verzögerter freigabe eines metallsalz eines peptids |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
US5869286A (en) | 1995-03-23 | 1999-02-09 | Immunex Corporation | Receptor that binds IL-17 |
DE69614685T2 (de) | 1995-06-07 | 2002-06-27 | Alkermes Inc | Mittel zur verzögerten freisetzung von menschlichem wachstumshormon |
ZA965368B (en) | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
CA2227220A1 (en) | 1995-07-19 | 1997-02-06 | Genetics Institute, Inc. | Human ctla-8 and uses of ctla-8-related proteins |
US6074849A (en) | 1995-07-19 | 2000-06-13 | Genetics Institute, Inc. | Polynucleotides encoding human CTLA-8 related proteins |
AU2582897A (en) | 1996-03-15 | 1997-10-01 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation |
WO2000053752A2 (en) | 1999-03-08 | 2000-09-14 | Genentech, Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
CN1258315A (zh) * | 1997-04-25 | 2000-06-28 | 津莫吉尼蒂克斯公司 | 哺乳动物细胞因子样因子7 |
EP1012260A4 (de) * | 1997-07-16 | 2001-05-09 | Human Genome Sciences Inc | Interleukin-20 |
US6635443B1 (en) | 1997-09-17 | 2003-10-21 | Human Genome Sciences, Inc. | Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein |
US6562578B1 (en) * | 1999-01-11 | 2003-05-13 | Schering Corporation | IL-17-like cytokine binding compounds and antibodies |
WO1999032632A1 (en) * | 1997-12-19 | 1999-07-01 | Millennium Pharmaceuticals, Inc. | Novel embryo-derived interleukin related factor molecules and uses therefor |
WO1999035267A1 (en) * | 1998-01-09 | 1999-07-15 | Immunex Corporation | Human and murine il-17d, cytokine related to interleukin-17: dna and polypeptides |
ES2312205T3 (es) | 1998-03-10 | 2009-02-16 | Genentech, Inc. | Nuevo polipeptido y acidos nucleicos que lo codifican. |
EP1386931B1 (de) | 1998-03-25 | 2006-05-10 | Genentech, Inc. | Menschliches Neurotrimin-Homolog |
DE69936382T3 (de) | 1998-05-15 | 2011-07-07 | Genentech, Inc., Calif. | Therapeutische verwendungen von il-17 homologe polypeptide |
EP1443055A3 (de) * | 1998-05-29 | 2005-06-08 | Human Genome Sciences, Inc. | Interleukine-21 und 22 |
EP1082433A4 (de) * | 1998-05-29 | 2003-01-02 | Human Genome Sciences Inc | Interleukine 21 und 22 |
US20010023070A1 (en) * | 1998-05-29 | 2001-09-20 | Reinhard Ebner | Interleukins-21 and 22 |
IL141869A0 (en) | 1998-09-17 | 2002-03-10 | Zymogenetics Inc | Mammalian transforming growth factor beta-9 (ztgfss9) |
WO2000020593A1 (en) * | 1998-10-02 | 2000-04-13 | Eli Lilly And Company | Il-17 homolog nucleic acids, polypeptides, vectors, host cells, methods and uses thereof |
AU3632600A (en) | 1999-05-14 | 2000-12-05 | Genentech Inc. | Compositions and methods for the treatment of immune related diseases |
AU6069800A (en) | 1999-07-07 | 2001-01-30 | Zymogenetics Inc. | Human cytokine receptor |
EP1208202A2 (de) | 1999-09-01 | 2002-05-29 | Genentech, Inc. | Ausgeschiedene und transmembran-polypeptide und dafür kodierende nukleinsäure |
ATE444361T1 (de) | 1999-12-23 | 2009-10-15 | Genentech Inc | Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen |
EP1254221A2 (de) | 2000-01-06 | 2002-11-06 | Protegene Inc. | Humane proteine mit hydrophoben domänen und diese kodierende dnas |
EP1285084A1 (de) | 2000-01-25 | 2003-02-26 | Hyseq, Inc. | Neuartige nukleinsäure und polypeptide |
WO2001055321A2 (en) | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
US7094886B2 (en) | 2000-02-04 | 2006-08-22 | Board Of Trustees Of The University Of Arkansas | Evi27 gene sequences and protein encoded thereby |
AU6802801A (en) | 2000-03-01 | 2001-09-24 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
JP2003526370A (ja) | 2000-03-16 | 2003-09-09 | アムジェン インコーポレーテッド | Il−17レセプター様分子およびその使用 |
TWI322154B (en) | 2000-03-16 | 2010-03-21 | Amgen Inc | Il-17 receptor like molecules and uses thereof |
CA2410083A1 (en) | 2000-05-24 | 2001-11-29 | Schering Corporation | Mammalian receptor proteins; related reagents and methods |
JP2004504064A (ja) | 2000-06-22 | 2004-02-12 | アムジエン・インコーポレーテツド | Il−17分子およびその用途 |
CA2412211A1 (en) | 2000-06-23 | 2002-01-03 | Genetech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
JP2004516013A (ja) | 2000-07-20 | 2004-06-03 | ジェネンテック・インコーポレーテッド | 血管形成に関連する障害を診断及び治療するための組成物と方法 |
EP1332211A2 (de) * | 2000-07-26 | 2003-08-06 | ZymoGenetics, Inc. | Menschlicher cytokinerezeptor |
DE60125563T2 (de) * | 2000-10-13 | 2007-10-04 | Eli Lilly And Co., Indianapolis | Verfahren zur verwendung eines humanen il-17 verwandten polypeptids zur behandlung von krankheiten |
AU2002324625B2 (en) | 2001-08-07 | 2008-05-08 | Immunex Corporation | Interleukin-1 receptors in the treatment of diseases |
DK1576011T3 (da) | 2002-10-30 | 2009-11-30 | Genentech Inc | Inhibering af IL-17 produktion |
DE602004030341D1 (de) | 2003-06-23 | 2011-01-13 | Genetics Inst Llc | Antikörper gegen interleukin-22 und verwendungen dafür |
SI2784084T2 (sl) | 2003-07-08 | 2024-02-29 | Novartis Pharma Ag | Antagonistična protitelesa proti IL-17 A/F heterolognim polipeptidom |
WO2006132788A2 (en) * | 2005-06-06 | 2006-12-14 | Genentech, Inc. | Transgenic models for different genes and their use for gene characterization |
-
1999
- 1999-05-14 DE DE69936382T patent/DE69936382T3/de not_active Expired - Lifetime
- 1999-05-14 IL IL13893099A patent/IL138930A0/xx unknown
- 1999-05-14 JP JP2000549734A patent/JP3577586B2/ja not_active Expired - Fee Related
- 1999-05-14 AT AT99923088T patent/ATE365800T1/de active
- 1999-05-14 WO PCT/US1999/010733 patent/WO1999060127A2/en active Application Filing
- 1999-05-14 DK DK99923088.1T patent/DK1076703T4/da active
- 1999-05-14 PT PT99923088T patent/PT1076703E/pt unknown
- 1999-05-14 AU AU39937/99A patent/AU740405B2/en not_active Expired
- 1999-05-14 NZ NZ508878A patent/NZ508878A/en not_active IP Right Cessation
- 1999-05-14 EP EP10010043A patent/EP2333069A3/de not_active Withdrawn
- 1999-05-14 CA CA2328496A patent/CA2328496C/en not_active Expired - Lifetime
- 1999-05-14 EP EP99923088A patent/EP1076703B2/de not_active Expired - Lifetime
- 1999-05-14 ES ES99923088T patent/ES2292242T5/es not_active Expired - Lifetime
-
2000
- 2000-10-06 IL IL138930A patent/IL138930A/en not_active IP Right Cessation
-
2001
- 2001-05-10 US US09/854,208 patent/US7217412B2/en not_active Expired - Lifetime
- 2001-05-10 US US09/854,280 patent/US7115398B2/en not_active Expired - Lifetime
-
2006
- 2006-05-19 US US11/436,554 patent/US20060205038A1/en not_active Abandoned
-
2007
- 2007-09-21 CY CY20071101224T patent/CY1106885T1/el unknown
-
2008
- 2008-07-31 IL IL193149A patent/IL193149A/en not_active IP Right Cessation
- 2008-08-07 US US12/188,054 patent/US7749500B2/en not_active Expired - Fee Related
-
2010
- 2010-05-26 US US12/788,129 patent/US8075888B2/en not_active Expired - Fee Related
-
2011
- 2011-12-08 US US13/315,061 patent/US20120128627A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE365800T1 (de) | Therapeutische verwendungen von il-17 homologe polypeptide | |
ATE447583T1 (de) | Polypeptide und dafür kodierende nukleinsäure | |
CY1112334T1 (el) | Ομολογα πολυπεπτιδια il-17 και θεραπευτικες χρησεις αυτων | |
DK1294876T3 (da) | EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse | |
DE69832539D1 (de) | Polypeptid und dafür kodierendes Nukeinsäure | |
KR100515858B1 (en) | PRO617 Polypeptides | |
ATE380864T1 (de) | Menschliches prostasin-ähnliches protein und dafür kodierende nukleinsäure | |
ATE415422T1 (de) | Menschliches gas-6 (growth arrest-specific gene 6) protein und dafür kodierende nukleinsäuren | |
KR100515856B1 (en) | PRO618 Polypeptides | |
KR100515857B1 (en) | PRO792 Polypeptides | |
DE69939227D1 (de) | Menschliches A33-Antigen-ähnliches Protein und dafür kodierende Nukleinsäure | |
DE69827532D1 (de) | Polypeptide und dafür kodierende Nukleinsäure | |
ATE404585T1 (de) | Menschliches synaptogyrin-ähnliches protein und dafür kodierende nukleinsäure | |
ATE405590T1 (de) | Menschliches hcar-ähnliches protein und dafür kodierende nukleinsäure | |
DE69829230D1 (de) | Polypeptid und dafür kodieredes Nukleinsäure | |
DK1191101T3 (da) | PRO241 polypeptider og nucleinsyre kodende herfor | |
EP1865061A3 (de) | IL-17-homologe Polypeptide und ihre therapeutische Verwendung | |
DE69829417D1 (de) | Polypeptide und dafür kodierende Nukleinsäure |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1076703 Country of ref document: EP |
|
UEP | Publication of translation of european patent specification |
Ref document number: 1076703 Country of ref document: EP |